Induction of Ceruloplasmin Synthesis by IFN-γ in Human Monocytic Cells

Journal of Immunology

Volumn 159, Issue 4, 1997, Pages 1938-1944

  Mazumder, Barsanjit ^a   Mukhopadhyay, Chinmay K ^a   Prok, Alan ^a   Cathcart, Martha K ^a   Fox, Paul L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; GAMMA INTERFERON; MESSENGER RNA;

ARTICLE; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MONOCYTE; NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER;

NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER;

CELL LINE; CERULOPLASMIN; HUMANS; INTERFERON TYPE II; MONOCYTES; RNA, MESSENGER;

EID: 0031571216     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Church, W. R., R. L. Jernigan, J. Toole, R. M. Hewick, J. Knopf, G. J. Knutson, M. E. Nesheim, K. G. Mann, and D. N. Fass. 1984. Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins. Proc. Natl. Acad. Sci. USA 81:6934.
2. Zaitseva, I., V. Zaitsev, G. Card, K. Moshkov, B. Bax, A. Ralph, and P. Lindley. 1996. The x-ray structure of human ceruloplasmin at 3.1Å: nature of the copper centres. J. Biol. lnorg. Chem. 1:15.
3. Samokyszyn, V. M., D. M. Miller, D. W. Reif, and S. D. Aust. 1989. Inhibition of Superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. J. Biol. Chem. 264:21.
4. Gutteridge, J. M. C. 1983. Antioxidant properties of caeruloplasmin towards iron-and copper-dependent oxygen radical formation. FEBS Lett. 157:37.
5. Lamb, D. J., and D. S. Leake. 1994. Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein. FEBS Lett. 138:122.
6. Swain, J. A., V. Darley-Usmar, and J. M. C. Gutteridge. 1994. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett. 342:49.
7. Van Lenten, B. J., S. Y. Hama, F. C. De Beer, D. M. Stafforini, T. M. McIntyre, S. M. Prescott, B. N. La Du, A. M. Fogelman, and M. Navab. 1995. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invist. 96:2758.
8. Ehrenwald, E., G. M. Chisolm, and P. L. Fox. 1994. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin. Invest. 93:1493.
9. Saenko, E. L., A. I. Yaropolov, and E. D. Harris. 1994. Biological functions of ceruloplasmin expressed through copper-binding sites and a cellular receptor. J. Trace Elem. Exp. Med. 7:69.
10. Rydén, L. 1984. Ceruloplasmin. In Copper Proteins and Copper Enzymes, Vol. III. R. Lonite, ed. CRC Press, Boca Raton, p. 37.
11. Logan, J. I., K. B. Harveyson, G. B. Wisdom, A. E. Hughes, and G. P. R. Archbold. 1994. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Q. J. Med. 87:663.
12. Harris, Z. L., Y. Takahashi, H. Miyajima, M. Serizawa, R. T. A. MacGillivray, and J. D. Gitlin. 1995. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Prof. Natl. Acad. Sci. USA 92:2539.
13. Yoshida, K., K. Furihata, S. Takeda, A. Nakamura, K. Yamamoto, H. Morita, S. Hiyamuta, S. Ikeda, N. Shimizu, and N. Yanagisawa. 1995. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9:267.
14. Stearman, R., D. S. Yuan, Y. Yamaguchi-Iwai, R. D. Klausner, and A. Dancis. 1996. A perrnease-oxidase complex involved in high-affinity iron uptake in yeast. Science 271:1552.
15. Gitlin, J. D. 1988. Transcriptional regulation of Ceruloplasmin gene expression during inflammation. J. Biol. Chem. 263:6281.
16. Ramadori, G., J. Van Damme, H. Rieder, and K.-H. Meyer zum Büschenfelde. 1988. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse: comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur. J. Immunol. 18:1259.
17. Fleming, R. E., I. P. Whitman, and J. D. Gitlin. 1991. Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia. Am. J. Physiol. 260: L68.
18. Weiner, A. L., and R. J. Cousins. 1983. Hormonally produced changes in caeruloplasmin synthesis and secretion in primary cultured rat hepatocytes: relationship to hepatic copper metabolism. Biochem. J. 212:297.
19. Jaeger, J. L., N. Shimizu, and J. D. Gitlin. 1991. Tissue-specific Ceruloplasmin gene expression in the mammary gland. Biochem. J. 280:671.
20. Schilsky, M. L., R. J. Stockert, and J. W. Pollard. 1992. Caeruloplasmin biosynthesis by the human uterus. Biochem. J. 288:657.
21. Aldred, A. R., A. Grimes, G. Schreiber, and J. F. Mercer. 1987. Rat ceruloplasmin: molecular cloning and gene expression in liver, choroid plexus, yolk sac, placenta, and testis. J. Biol. Chem. 262:2875.
22. Fleming, R. E., and J. D. Gillin. 1990. Primary structure of rat Ceruloplasmin and analysis of tissue-specific gene expression during development. J. Biol. Chem. 265:7701.
23. Klomp, L. W. J., and J. D. Gitlin. 1996. Expression of the Ceruloplasmin gene in the human retina and brain: implications lor a pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 5:1989.
24. Yang, F. S. L. Naylor, J. B. Lum, S. Cutshaw, J. L. McCombs, K. H. Naberhaus, J. R. McGill, G. S. Adrian, C. M. Moore, D. R. Barnett, and B. H. Bowman. 1986. Characterization, mapping, and expression of the human Ceruloplasmin gene. Proc. Natl. Acad. Sci. USA 83:3257.
25. Yang, F., W. E. Friedrichs, R. L. Cupples, M. J. Bonifacio, J. A. Sanford, W. A. Horton, and B. H. Bowman. 1990. Human Ceruloplasmin: tissue-specific expression of transcripts produced by alternative splicing. J. Biol. Chem. 265: 10780.
26. Ehrenwald, E., and P. L. Fox. 1996. Role of endogenous Ceruloplasmin in LDL oxidation by human U937 monocytic cells. J. Clin. Invest. 97:884.
27. Finbloom, D. S., D. L. Hoover, and L. M. Wahl. 1985. The characteristics of binding of human recombinant interferon-gamma to its receptor on human monocytes and human monocyte-like cell lines. J. Immunol. 135:300.
28. Inoue, S., S.-I. Itagaki, and F. Amano. 1995. Intracellular killing of Listeria monocytogenes in the J774.1 macrophage-like cell line and the lipopolysaccharide (LPS)-resistant mutant LPS1916 cell line defective in the generation of reactive oxygen intermediates after LPS treatment. Infect. Immun. 63:1876.
29. Byrd, T. F., and M. A. Horwitz. 1989. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J. Clin. Invest. 83:1457.
30. Marodi, L., S. Schreiber, D. C. Anderson, R. P. MacDermott, H. M. Korchak, and R. B. Johnston. 1993. Enhancement of macrophage candidacidal activity by interferon-gamma: increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Invest. 91:2596.
31. Karhumäki, E., and H. Helin. 1987. Regulation of oxidative metabolism by interferon-γ during human monocyte to macrophage differentiation. Med. Biol. 65:261.
32. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571.
33. Unanue, E. R., and P. M. Allen. 1987. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236:551.
34. Erbe, D. V., J. E Collins, L. Shen, R. F. Graziano, and M. W. Fanger. 1990. The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Mol. Immunol. 27:57.
35. Strunk, R. C . F. S. Cole, D. H. Perlmutter, and H. R. Colten. 1985. γ-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. J. Biol. Chem. 260:15280.
36. Wietzerbin, J., C. Gaudelet, L. Catinot, J. Chebath, and R. Falcoff, 1990. Synergistic effect of interferon-γ and tumor necrosis factor-α on antiviral activity and (2′-5′) oligo (A) synthetase induction in a myelomonocytic cell line. J. Leukocyte Biol. 48:149.
37. 2+, ceruloplasmin, and phosphate. Arch. Biochem. Biophys. 295:302.
38. Cathcart, M. K., D. W. Morel, and G. M. Chisolm. 1985. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J. Leukocyte Biol. 38:341.
39. Sehen, R. J., and M. Rabinovitz. 1966. Differential staining of ceruloplasmin as an aid to interpretation in immunoelectrophoresis. Clin. Chim. Acta 13:537.
40. Luster, A. D., J. C. Unkeless, and J. V. Ravelch. 1985. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672.
41. Koschinsky, M. L., W. D. Funk, B. A. van Oost, and R. T. MacGillivray. 1986. Complete cDNA sequence of human preceruloplasmin. Proc. Natl. Acad. Sci. USA 83:5086.
42. Pearse, R. N., R. Feinman, and J. V. Ravetch. 1991. Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by γ-interferon is mediated through common DNA response elements. Proc. Natl. Acad. Sci. USA 88:11305.
43. Stein, J., H. D. Volk, C. Liebenthal, D. H. Krüger, and S. Prösch. 1993. Tumour necrosis factor a stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J. Gen. Virol. 74:2333.
44. Sato, M., and J. D. Gitlin. 1991. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J. Biol. Chem. 266:5128.
45. Caldenhoven, E., P. Coffer, J. Yuan, A. Van de Stolpe, F. Horn, W. Kruijer, and P. T. Van der Saag. 1994. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-7 involves binding of distinct factors to a palindromic response element. J. Biol. Chem. 269:21146.
46. Klemsz, M. J., S. R. McKercher, A. Celada, C. Van Beveren, and R. A. Maki. 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113.
47. Shackelford, R., D. O. Adams, and S. P. Johnson. 1995. IFN-gamma and lipopolysaccharide induce DNA binding of transcription factor PU.1 in murine tissue macrophages. J. Immunol. 154:1374.
48. Christen, S., S. R. Thomas, B. Garner, and R. Stocker. 1994. Inhibition by interferon-γ of human mononuclear cell-mediated low density lipoprotein oxidation: participation of tryptophan metabolism along the kynurenine pathway. J. Clin. Invest. 93:2149.
49. Ragan, H. A., S. Nacht, G. R. Lee, C. R. Bishop, and G. E. Cartwright. 1969. Effect of ceruloplasmin on plasma iron in copper-deficient swine. Am. J. Physiol. 217:1320.
50. Osaki, S., and D. A. Johnson. 1969. Mobilization of liver iron by ferroxidase (ceruloplasmin). J. Biol. Chem. 244:5757.
51. Osaki, S., D. A. Johnson, and E. Frieden. 1966. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241:2746.
52. Weinberg, E. D. 1992. Iron depletion: a defense against intracellular infection and neoplasia. Life Sci. 50:1289.